Medicare Enrolled
Dr. Bhaskara Madhira, MD
Hematology & Oncology · Abilene, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Madhira from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Madhira?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Madhira
Dr. Bhaskara Madhira is a hematology & oncology specialist in Abilene, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Madhira performed 12,882 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Madhira received a total of $776 from 15 pharmaceutical and/or device companies across 18 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Madhira is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 36% volume in TX
$776 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗12,882
Medicare services
Top 36% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
8,160 | $0 | $5 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,675 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
369 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
310 | $8 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
246 | $90 | $360 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
246 | $0 | $1 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
221 | $10 | $64 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
141 | $58 | $247 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
91 | $62 | $227 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
77 | $129 | $476 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
61 | $13 | $60 |
| Albumin level test A blood test that measures the amount of albumin, a protein made by the liver, in your body. |
60 | $5 | $28 |
| Total bilirubin level test A blood test that measures the total amount of bilirubin, a waste product from the breakdown of red blood cells, in your body. |
60 | $5 | $23 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
60 | $5 | $30 |
| Carbon dioxide level test A blood test that measures the amount of carbon dioxide in your blood, which helps evaluate your body's acid-base balance and kidney function. |
60 | $5 | $24 |
| Blood chloride level test A laboratory test that measures the amount of chloride in a blood sample. Chloride is an electrolyte that helps maintain fluid balance and acid-base levels in the body. |
60 | $5 | $25 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
60 | $5 | $31 |
| Iron level test | 60 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
60 | $9 | $35 |
| Alkaline phosphatase level test A blood test that measures the level of alkaline phosphatase, an enzyme found in the liver and bones. |
60 | $5 | $27 |
| Blood potassium level test A blood test that measures the amount of potassium in your body. Potassium is an electrolyte that helps control heart and muscle function. |
60 | $5 | $30 |
| Total protein blood test A blood test that measures the total amount of protein in your blood. This test helps evaluate your overall health and nutritional status. |
60 | $4 | $42 |
| Liver enzyme (SGOT) level test A blood test that measures the level of the liver enzyme SGOT to help assess liver health. |
60 | $5 | $33 |
| Liver enzyme (SGPT) level test A blood test that measures the level of the liver enzyme SGPT to assess liver function. |
60 | $5 | $28 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
60 | $4 | $24 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
47 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
47 | $6 | $34 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
44 | $6 | $31 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
42 | $101 | $707 |
| New patient office visit, complex (60-74 min) | 35 | $149 | $592 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
33 | $22 | $157 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
31 | $90 | $318 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $133 | $655 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $94 | $565 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
29 | $42 | $142 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
20 | $49 | $313 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
17 | $5 | $26 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
15 | $50 | $344 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
14 | $19 | $99 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
12 | $63 | $220 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
64.2% high complexity
14.9% medium
20.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$776
Total received (2020-2024)
Avg $155/year across 5 years
Bottom 25% in TX for hematology & oncology
15
Companies
18
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$29
2023
$376
2022
$304
2021
$51
2020
$15
Payments by company (2024)
Geron Corporation
$29
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2020-2024) ›
Amgen Inc.
$130
CTI BioPharma Corp.
$108
PharmaEssentia USA Corporation
$97
Alexion Pharmaceuticals, Inc.
$85
Janssen Biotech, Inc.
$82
Gilead Sciences, Inc.
$79
Novartis Pharmaceuticals Corporation
$36
Geron Corporation
$29
PFIZER INC.
$24
GENZYME CORPORATION
$22
Sobi, Inc
$20
TerSera Therapeutics LLC
$18
E.R. Squibb & Sons, L.L.C.
$15
Celgene Corporation
$14
Dova Pharmaceuticals
$14
Top 3 companies account for 43.3% of all-time payments
Associated products mentioned in payments ›
BESREMI · BOSULIF · DOPTELET · Doptelet · ERLEADA · Kyprolis · LUTATHERA · MEKINIST · Nplate · OPDIVO · REBLOZYL · RYTELO · SARCLISA · Trodelvy · Vonjo · Xermelo
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
5
County median income
$66,406
Nearest hospital to ZIP centroid (approximate)
OCEANS BEHAVIORAL HOSPITAL OF ABILENE
8.9 mi
8.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Madhira is a mixed practice specialist, with moderate Medicare volume, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Madhira experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Madhira performed 8,160 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Madhira receive payments from pharmaceutical companies?
Yes. Dr. Madhira received a total of $776 from 15 companies across 18 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Madhira's costs compare to other hematology & oncology specialists in Abilene?
Dr. Madhira's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Madhira) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Abilene
Browse hematology & oncology specialists in Abilene ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
CTI BioPharma Corp. Payments to Doctors
See all physicians who received payments from CTI BioPharma Corp.
By company
PharmaEssentia USA Corporation Payments to Doctors
See all physicians who received payments from PharmaEssentia USA Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology